Society guideline links: COVID-19 – General guidelines for pre- and post-exposure prophylaxis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to other COVID-19 related guidelines are provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics".)

International

●World Health Organization (WHO): Drugs to prevent COVID-19 – Living guideline (2023)

United States

●National Institutes of Health (NIH): COVID-19 treatment guidelines

•Anti-SARS-CoV-2 monoclonal antibodies (2024)

•Prevention of SARS-CoV-2 infection (2023)

•Prioritization of anti-SARS-CoV-2 therapies for the treatment and prevention of COVID-19 when there are logistical or supply constraints (2023)

●Infectious Diseases Society of America (IDSA): Guidelines on the treatment and management of patients with COVID-19 (2021, updated 2023)